[Present-day principles of therapy in chronic myeloleukemia]

[An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].

Terapevticheskii arkhiv·1998

Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.

Cancer genetics and cytogenetics·1996

[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].

Terapevticheskii arkhiv·1996

[A comparative clinico-morphological analysis of acute myelo- and myelomonoblastic leukemias in children and adults].

Terapevticheskii arkhiv·1996

[Use of a new antimacrophage monoclonal antibody D11 in diagnosis of hemoblastosis].

Gematologiia i transfuziologiia·1995

[Megakaryocytic dysplasia in acute nonlymphoblastic leukemias].

Terapevticheskii arkhiv·1995

[Effect of laser irradiation of different intensities on the processes of healing of stomach ulcers].

Sovetskaia meditsina·1991

[Ultrasonic diagnosis of gastric motor-emptying disorders].

Sovetskaia meditsina·1991

[Pulmonary hypertension and myocardial contractility in myocarditis].

Sovetskaia meditsina·1991

Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

The oncologist·2026

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Oncoimmunology·2026

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Investigative and clinical urology·2026

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

Korean journal of radiology·2026

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Transfusion medicine (Oxford, England)·2026

Related Experiment Videos

[Present-day principles of therapy in chronic myeloleukemia]

Related Concept Videos

[An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].

Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.

[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].

[A comparative clinico-morphological analysis of acute myelo- and myelomonoblastic leukemias in children and adults].

[Use of a new antimacrophage monoclonal antibody D11 in diagnosis of hemoblastosis].

[Megakaryocytic dysplasia in acute nonlymphoblastic leukemias].

[Effect of laser irradiation of different intensities on the processes of healing of stomach ulcers].

[Ultrasonic diagnosis of gastric motor-emptying disorders].

[Pulmonary hypertension and myocardial contractility in myocarditis].

Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Related Experiment Videos

[Present-day principles of therapy in chronic myeloleukemia]

Related Concept Videos

Related Articles